Position in TBPH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,754,000
+$1,311,935 QoQ
Shares Held
416,143
+43.1% QoQ
Ownership
0.807%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Derivatives in TBPH
reported options exposure · as of Dec 31, 2022CallValue
$561,000
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $9,665,556,574 across 365 Biotechnology names. TBPH ranks #152 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in TBPH
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,754,000 | 416,143 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,442,065 | 290,864 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $3,776,260 | 258,648 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,199,226 | 199,386 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,880,086 | 210,536 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $2,118,218 | 225,103 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,335,697 | 289,789 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,828,511 | 333,551 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,998,066 | 222,750 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,217,910 | 286,291 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $2,328,244 | 269,785 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $3,525,199 | 340,599 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $3,650,232 | 336,427 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $3,881,928 | 345,983 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $561,000 | 50,000 | Call | Defined | 2024-05-14 | |
| 2022-09-30 | $507 | 50,000 | Call | Defined | 2024-05-14 | |
| 2022-09-30 | $6,315 | 622,859 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $5,282 | 583,029 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $9,334,125 | 976,373 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,798,890 | 343,791 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $2,251,501 | 304,257 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $4,178,260 | 287,759 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,737,659 | 281,120 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,210,774 | 349,509 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,659,714 | 315,165 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,009,505 | 333,945 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $3,933,552 | 170,210 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||